Search for: "Eli Lilly "
Results 1121 - 1140
of 2,131
Sort by Relevance
|
Sort by Date
7 Nov 2011, 7:51 am
That same year, Eli Lilly paid $1.4 billion to settle claims that it improperly marketed its antipsychotic drug Zyprexa for use in children and elderly patients. [read post]
4 Nov 2011, 9:58 am
Upon motion by Eli Lilly, a previous ruling in the case had invalidated the patent based on arguments from Eli Lilly that the claimed uses of the synthesized protein were too vague. [read post]
4 Nov 2011, 4:34 am
Eli Lilly & Co v Human Genome Sciences Inc [2011] UKSC 51; [2011] WLR (D) 312 “Since the Technical Board of Appeal of the European Patent Office had adopted a consistent approach to patents for biological material, the English courts should follow the principles of law set out in its decisions. [read post]
3 Nov 2011, 3:42 am
Supreme Court Rainy Sky SA & Orsd v Kookmin Bank [2011] UKSC 50 (2 November 2011) Human Genome Sciences Inc v Eli Lilly and Company [2011] UKSC 51 (2 November 2011) Court of Appeal (Civil Division) Smith & Anor v Jafton Properties Ltd [2011] EWCA Civ 1251 (02 November 2011) Shiva Ltd v Transport for London [2011] EWCA Civ 1189 (02 November 2011) High Court (Chancery Division) Business Dream Ltd, Re Insolvency Act 1986 [2011] EWHC 2860 (Ch) (02 November 2011) High… [read post]
2 Nov 2011, 11:56 pm
Human Genome Sciences Inc (Appellant) v Eli Lilly and Company (Respondent) [see judgment, press summary, BAILII] In holding that gene sequences can have industrial application, reversing the lower courts’ findings, the Supreme Court gave primacy two policy arguments- attracting biosciences investment into the UK and bringing UK interpretations in compliance with the European Patent Convention. [read post]
2 Nov 2011, 11:56 pm
Human Genome Sciences Inc (Appellant) v Eli Lilly and Company (Respondent) [see judgment, press summary, BAILII] In holding that gene sequences can have industrial application, reversing the lower courts’ findings, the Supreme Court gave primacy two policy arguments- attracting biosciences investment into the UK and bringing UK interpretations in compliance with the European Patent Convention. [read post]
2 Nov 2011, 8:46 pm
Eli Lilly (UK Supreme Court, 2 Nov 2011) [Decision] Case No. [2011] UKSC 51. [read post]
2 Nov 2011, 12:57 pm
Still, you can’t blame the inventor for trying… The dispute in Human Genome Sciences v Eli Lilly is, by comparison, a whole other kettle of fish. [read post]
2 Nov 2011, 5:40 am
Supreme Court Rainy Sky SA & Orsd v Kookmin Bank [2011] UKSC 50 (2 November 2011) Human Genome Sciences Inc v Eli Lilly and Company [2011] UKSC 51 (2 November 2011) Court of Appeal (Civil Division) MD (Angola) & Ors, R (on the application of) v Secretary of State for the Home Department & Anor [2011] EWCA Civ 1238 (01 November 2011) Mitu v London Borough of Camden [2011] EWCA civ 1249 (01 November 2011) Williams v University of Birmingham & Anor [2011] EWCA Civ 1242… [read post]
2 Nov 2011, 4:53 am
Meanwhile, the Respondent [Eli Lilly] brought parallel proceedings in the High Court for revocation of the Patent in the UK. [read post]
2 Nov 2011, 3:24 am
On appeal from: [2010] EWCA Civ 33. [read post]
31 Oct 2011, 3:42 am
A. v Kookmin Bank, heard 27 July 2011, and Human Genome Sciences Inc v Eli Lilly and Company, heard 18 – 21 July 2011. [read post]
28 Oct 2011, 7:22 am
IN - Judge Tanya Walton Pratt of the Southern District of Indiana has granted a Partial Summary Judgment for Eli Lilly and Company of Indianapolis, Indiana in a dispute with licensee Valeant Pharmaceuticals International of Irvine, California involving the costs associated with product liability lawsuits over Lilly's Parkinson's disease drug. [read post]
28 Oct 2011, 7:00 am
Eli Lilly & Co., 2009 WL 5216930, at *12 (E.D.N.Y. [read post]
27 Oct 2011, 11:48 am
Exactly who is to blame if a pharmaceutical company, say Eli Lilly, decides to invest billions of dollars and build a facility when they haven't adequately protected their own intellectual property? [read post]
27 Oct 2011, 4:24 am
Eli Lilly paid $1.4 billion for Zyprexa marketing. [read post]
26 Oct 2011, 7:59 am
Zyprexa, you may know, has serious side-effects that can lead to diabetes and its manufacturer, Eli Lilly, has been sued by tens of thousands of ill Zyprexa users, telling salespeople to downplay these side effects. [read post]
25 Oct 2011, 6:28 pm
Eli Lilly and Co withdrew its sepsis drug Xigris from all markets after the product, deemed a potential big seller when it was approved a decade ago, failed to improve survival in a clinical trial.Sepsis is a severe, often life-threatening illness caused by the immune system's over-aggressive response to infections -- releasing inflammatory proteins that cause shock and shut down multiple organs. [read post]
24 Oct 2011, 9:36 am
Eli Lilly and Co., No. 2008-1248 (Fed. [read post]
24 Oct 2011, 2:52 am
Human Genome Sciences Inc v Eli Lilly and Company, heard 18 July 2011. [read post]
